Cormorant Asset Management »

Cargo Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Cargo Therapeutics (CRGX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Cargo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cargo Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cargo Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $14M 3.4M 4.12
2025-03-31 $14M 3.4M 4.07
2024-12-31 $17M 1.2M 14.42
2024-09-30 $22M 1.2M 18.45
2024-06-30 $19M 1.2M 16.42
2024-03-31 $26M 1.2M 22.32
2023-12-31 $27M 1.2M 23.15

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Cargo Therapeutics

Morgan Stanley
IFP Advisors

View all funds holding Cargo Therapeutics